Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Terslev, L, Naredo, E, Keen, HI, Bruyn, GAW, Iagnocco, A, Wakefield, RJ, Conaghan, PG, Maxwell, LJ, Beaton, DE, Boers, M & D'Agostino, M-A 2019, 'The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example' Journal of Rheumatology, bind 46, nr. 10, s. 1394-1400. https://doi.org/10.3899/jrheum.181158

APA

CBE

Terslev L, Naredo E, Keen HI, Bruyn GAW, Iagnocco A, Wakefield RJ, Conaghan PG, Maxwell LJ, Beaton DE, Boers M, D'Agostino M-A. 2019. The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example. Journal of Rheumatology. 46(10):1394-1400. https://doi.org/10.3899/jrheum.181158

MLA

Vancouver

Author

Terslev, Lene ; Naredo, Esperanza ; Keen, Helen I ; Bruyn, George A W ; Iagnocco, Annamaria ; Wakefield, Richard J ; Conaghan, Philip G ; Maxwell, Lara J ; Beaton, Dorcas E ; Boers, Maarten ; D'Agostino, Maria-Antonietta. / The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments : The Musculoskeletal Ultrasound Example. I: Journal of Rheumatology. 2019 ; Bind 46, Nr. 10. s. 1394-1400.

Bibtex

@article{d143d56fe19f40998637b12c10942b62,
title = "The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example",
abstract = "OBJECTIVE: To describe the Outcome Measures in Rheumatology (OMERACT) stepwise approach to select and develop an imaging instrument with musculoskeletal ultrasound (US) as an example.METHODS: The OMERACT US Working Group (WG) developed a 4-step process to select instruments based on imaging. Step 1 applies the OMERACT Framework Instrument Selection Algorithm (OFISA) to existing US outcome measurement instruments for a specific indication. This step requires a literature review focused on the truth, discrimination, and feasibility aspects of the instrument for the target pathology. When the evidence is completely unsatisfactory, Step 2 is a consensus process to define the US characteristics of the target pathology including one or more so-called {"}elementary lesions{"}. Step 3 applies the agreed definitions to the image, evaluates their reliability, develops a severity grading of the lesion(s) at a given anatomical site, and evaluates the effect of the acquisition technique on feasibility and lesion(s) detection. Step 4 applies and assesses the definition(s) and scoring system(s) in cross-sectional studies and multicenter trials. The imaging instrument is now ready to pass a final OFISA check.RESULTS: With this process in place, the US WG now has 18 subgroups developing US instruments in 10 different diseases. Half of them have passed Step 3, and the groups for enthesitis (spondyloarthritis, psoriatic arthritis), synovitis, and tenosynovitis (rheumatoid arthritis) have finished Step 4.CONCLUSION: The US WG approach to select and develop outcome measurement instruments based on imaging has been repeatedly and successfully applied in US, but is generic for imaging and fits with OMERACT Filter 2.1.",
author = "Lene Terslev and Esperanza Naredo and Keen, {Helen I} and Bruyn, {George A W} and Annamaria Iagnocco and Wakefield, {Richard J} and Conaghan, {Philip G} and Maxwell, {Lara J} and Beaton, {Dorcas E} and Maarten Boers and Maria-Antonietta D'Agostino",
note = "COPECARE",
year = "2019",
month = "10",
doi = "10.3899/jrheum.181158",
language = "English",
volume = "46",
pages = "1394--1400",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology Publishing Co. Ltd",
number = "10",

}

RIS

TY - JOUR

T1 - The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments

T2 - The Musculoskeletal Ultrasound Example

AU - Terslev, Lene

AU - Naredo, Esperanza

AU - Keen, Helen I

AU - Bruyn, George A W

AU - Iagnocco, Annamaria

AU - Wakefield, Richard J

AU - Conaghan, Philip G

AU - Maxwell, Lara J

AU - Beaton, Dorcas E

AU - Boers, Maarten

AU - D'Agostino, Maria-Antonietta

N1 - COPECARE

PY - 2019/10

Y1 - 2019/10

N2 - OBJECTIVE: To describe the Outcome Measures in Rheumatology (OMERACT) stepwise approach to select and develop an imaging instrument with musculoskeletal ultrasound (US) as an example.METHODS: The OMERACT US Working Group (WG) developed a 4-step process to select instruments based on imaging. Step 1 applies the OMERACT Framework Instrument Selection Algorithm (OFISA) to existing US outcome measurement instruments for a specific indication. This step requires a literature review focused on the truth, discrimination, and feasibility aspects of the instrument for the target pathology. When the evidence is completely unsatisfactory, Step 2 is a consensus process to define the US characteristics of the target pathology including one or more so-called "elementary lesions". Step 3 applies the agreed definitions to the image, evaluates their reliability, develops a severity grading of the lesion(s) at a given anatomical site, and evaluates the effect of the acquisition technique on feasibility and lesion(s) detection. Step 4 applies and assesses the definition(s) and scoring system(s) in cross-sectional studies and multicenter trials. The imaging instrument is now ready to pass a final OFISA check.RESULTS: With this process in place, the US WG now has 18 subgroups developing US instruments in 10 different diseases. Half of them have passed Step 3, and the groups for enthesitis (spondyloarthritis, psoriatic arthritis), synovitis, and tenosynovitis (rheumatoid arthritis) have finished Step 4.CONCLUSION: The US WG approach to select and develop outcome measurement instruments based on imaging has been repeatedly and successfully applied in US, but is generic for imaging and fits with OMERACT Filter 2.1.

AB - OBJECTIVE: To describe the Outcome Measures in Rheumatology (OMERACT) stepwise approach to select and develop an imaging instrument with musculoskeletal ultrasound (US) as an example.METHODS: The OMERACT US Working Group (WG) developed a 4-step process to select instruments based on imaging. Step 1 applies the OMERACT Framework Instrument Selection Algorithm (OFISA) to existing US outcome measurement instruments for a specific indication. This step requires a literature review focused on the truth, discrimination, and feasibility aspects of the instrument for the target pathology. When the evidence is completely unsatisfactory, Step 2 is a consensus process to define the US characteristics of the target pathology including one or more so-called "elementary lesions". Step 3 applies the agreed definitions to the image, evaluates their reliability, develops a severity grading of the lesion(s) at a given anatomical site, and evaluates the effect of the acquisition technique on feasibility and lesion(s) detection. Step 4 applies and assesses the definition(s) and scoring system(s) in cross-sectional studies and multicenter trials. The imaging instrument is now ready to pass a final OFISA check.RESULTS: With this process in place, the US WG now has 18 subgroups developing US instruments in 10 different diseases. Half of them have passed Step 3, and the groups for enthesitis (spondyloarthritis, psoriatic arthritis), synovitis, and tenosynovitis (rheumatoid arthritis) have finished Step 4.CONCLUSION: The US WG approach to select and develop outcome measurement instruments based on imaging has been repeatedly and successfully applied in US, but is generic for imaging and fits with OMERACT Filter 2.1.

U2 - 10.3899/jrheum.181158

DO - 10.3899/jrheum.181158

M3 - Journal article

VL - 46

SP - 1394

EP - 1400

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 10

ER -

ID: 58907496